148 related articles for article (PubMed ID: 9020337)
1. Immunologic barriers to hepatic adenoviral gene therapy for transplantation.
DeMatteo RP; Chu G; Ahn M; Chang E; Burke C; Raper SE; Barker CF; Markmann JF
Transplantation; 1997 Jan; 63(2):315-9. PubMed ID: 9020337
[TBL] [Abstract][Full Text] [Related]
2. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues.
Yang Y; Su Q; Grewal IS; Schilz R; Flavell RA; Wilson JM
J Virol; 1996 Sep; 70(9):6370-7. PubMed ID: 8709265
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer to the thymus. A means of abrogating the immune response to recombinant adenovirus.
DeMatteo RP; Raper SE; Ahn M; Fisher KJ; Burke C; Radu A; Widera G; Claytor BR; Barker CF; Markmann JF
Ann Surg; 1995 Sep; 222(3):229-39; discussion 239-42. PubMed ID: 7677454
[TBL] [Abstract][Full Text] [Related]
5. Effect of adenoviral early genes and the host immune system on in vivo pancreatic gene transfer in the mouse.
McClane SJ; Hamilton TE; DeMatteo RP; Burke C; Raper SE
Pancreas; 1997 Oct; 15(3):236-45. PubMed ID: 9336786
[TBL] [Abstract][Full Text] [Related]
6. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.
Yang Y; Haecker SE; Su Q; Wilson JM
Hum Mol Genet; 1996 Nov; 5(11):1703-12. PubMed ID: 8922997
[TBL] [Abstract][Full Text] [Related]
7. Impairment of force generation after adenovirus-mediated gene transfer to muscle is alleviated by adenoviral gene inactivation and host CD8+ T cell deficiency.
Petrof BJ; Lochmüller H; Massie B; Yang L; Macmillan C; Zhao JE; Nalbantoglu J; Karpati G
Hum Gene Ther; 1996 Oct; 7(15):1813-26. PubMed ID: 8894673
[TBL] [Abstract][Full Text] [Related]
8. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver.
Alzuguren P; Hervas-Stubbs S; Gonzalez-Aseguinolaza G; Poutou J; Fortes P; Mancheno U; Bunuales M; Olagüe C; Razquin N; Van Rooijen N; Enguita M; Hernandez-Alcoceba R
Liver Int; 2015 Apr; 35(4):1274-89. PubMed ID: 24754307
[TBL] [Abstract][Full Text] [Related]
9. Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion.
DeMatteo RP; Markmann JF; Kozarsky KF; Barker CF; Raper SE
Gene Ther; 1996 Jan; 3(1):4-12. PubMed ID: 8929906
[TBL] [Abstract][Full Text] [Related]
10. Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses.
Worgall S; Busch A; Rivara M; Bonnyay D; Leopold PL; Merritt R; Hackett NR; Rovelink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
J Virol; 2004 Mar; 78(5):2572-80. PubMed ID: 14963160
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.
Jooss K; Yang Y; Wilson JM
Hum Gene Ther; 1996 Aug; 7(13):1555-66. PubMed ID: 8864756
[TBL] [Abstract][Full Text] [Related]
12. Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody.
Chirmule N; Truneh A; Haecker SE; Tazelaar J; Gao Gp; Raper SE; Hughes JV; Wilson JM
J Immunol; 1999 Jul; 163(1):448-55. PubMed ID: 10384148
[TBL] [Abstract][Full Text] [Related]
13. Cellular immunity delimits adenoviral gene therapy strategies for the treatment of neoplastic diseases.
DeMatteo RP; Yeh H; Friscia M; Caparrelli D; Burke C; Desai N; Chu G; Markmann JF; Raper SE; Barker CF
Ann Surg Oncol; 1999; 6(1):88-94. PubMed ID: 10030420
[TBL] [Abstract][Full Text] [Related]
14. DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle.
Chen HH; Mack LM; Choi SY; Ontell M; Kochanek S; Clemens PR
Hum Gene Ther; 1999 Feb; 10(3):365-73. PubMed ID: 10048389
[TBL] [Abstract][Full Text] [Related]
15. Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.
Ilan Y; Prakash R; Davidson A; Jona ; Droguett G; Horwitz MS; Chowdhury NR; Chowdhury JR
J Clin Invest; 1997 Mar; 99(5):1098-106. PubMed ID: 9062369
[TBL] [Abstract][Full Text] [Related]
16. Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses.
Ilan Y; Sauter B; Chowdhury NR; Reddy BV; Thummala NR; Droguett G; Davidson A; Ott M; Horwitz MS; Chowdhury JR
Hepatology; 1998 May; 27(5):1368-76. PubMed ID: 9581693
[TBL] [Abstract][Full Text] [Related]
17. Sustained muscle expression of dystrophin from a high-capacity adenoviral vector with systemic gene transfer of T cell costimulatory blockade.
Jiang Z; Schiedner G; van Rooijen N; Liu CC; Kochanek S; Clemens PR
Mol Ther; 2004 Oct; 10(4):688-96. PubMed ID: 15451453
[TBL] [Abstract][Full Text] [Related]
18. Overcoming cellular immunity to prolong adenoviral-mediated gene expression in sciatic nerve.
Jani A; Menichella D; Jiang H; Chbihi T; Acsadi G; Kamholz J; Shy ME
Ann N Y Acad Sci; 1999 Sep; 883():397-414. PubMed ID: 10586264
[TBL] [Abstract][Full Text] [Related]
19. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.
Jooss K; Turka LA; Wilson JM
Gene Ther; 1998 Mar; 5(3):309-19. PubMed ID: 9614550
[TBL] [Abstract][Full Text] [Related]
20. Quality of the transgene-specific CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination.
Holst PJ; Ørskov C; Thomsen AR; Christensen JP
J Immunol; 2010 Apr; 184(8):4431-9. PubMed ID: 20212099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
